Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Safe Stocks to Buy for the Long Term in 2026

In this article, we will take a look at the 5 Safe Stocks to Buy for the Long Term in 2026. For deeper discussion and analysis, read 10 Safe Stocks to Buy for the Long Term in 2026. 

Image by Alexsander-777 from Pixabay

5. Exxon Mobil Corporation (NYSE:XOM)

Number of Hedge Fund Holders: 94

On May 27, Mizuho raised the firm’s price recommendation on Exxon Mobil Corporation (NYSE:XOM) to $175 from $159. It reiterated a Neutral rating on the shares. The firm said it expects the impact of the Iran crisis on global oil prices and refining cracks to last longer than previously expected. Mizuho raised its 2026 and 2027 oil price outlooks by 25% and 6%, respectively. It also increased its forecasts for US refining cracks by 61% and 51%. According to the analyst, the recent pullback in stock valuations, despite elevated commodity prices, is creating opportunities for investors looking to generate “alpha” in the US oil and gas sector. The firm also adjusted ratings and price targets across the group.

On May 26, Barclays analyst Betty Jiang raised the firm’s price goal on XOM to $182 from $163 and kept an Overweight rating on the shares. The firm said declining inventories, reduced OPEC spare capacity, and a “muted” U.S. production response to the Middle East conflict are contributing to a tighter oil market backdrop that is not fully reflected in energy stocks. The analyst added in a research note that this environment could lead to a share re-rating for more “oily” exploration and production companies after the conflict. Barclays also lowered its gas price outlook because of near-term oversupply and adjusted ratings and price targets across the integrated oil and exploration and production sector.

Exxon Mobil Corporation (NYSE:XOM) is an energy provider and chemical manufacturer. The company’s main operations include the exploration and production of crude oil and natural gas, along with the manufacturing, transportation, trade, and sale of petroleum products, petrochemicals, and specialty products.

4. Cisco Systems, Inc. (NASDAQ:CSCO)

Number of Hedge Fund Holders: 97

On May 26, BofA raised the firm’s price target on Cisco Systems, Inc. (NASDAQ:CSCO) to $135 from $114. It reiterated a Buy rating on the shares. The analyst said Cisco’s recent fiscal Q3 results, along with management’s comments about continued strong demand for Acacia, support a positive view on the underlying demand environment for optical networking.

On May 15, HSBC upgraded CSCO to Buy from Hold. It raised its price target on the stock to $137 from $77. As previously reported, the firm said the company delivered a “modest” beat in fiscal Q3, though new AI orders shifted the conversation around future growth. Management expects FY27 AI revenue to reach at least $6B, which implies roughly 50% year-over-year growth, the analyst told investors. HSBC said stronger momentum in AI infrastructure and improved earnings visibility were key reasons behind the rating upgrade and higher price target.

Cisco Systems, Inc. (NASDAQ:CSCO) designs and sells a range of technologies that power the internet. The company is integrating its product portfolios across networking, security, collaboration, applications, and cloud services.

3. UnitedHealth Group Incorporated (NYSE:UNH)

Number of Hedge Fund Holders: 130

On May 27, Bernstein raised the firm’s price target on UnitedHealth Group Incorporated (NYSE:UNH) to $492 from $444 and maintained an Outperform rating on the shares. The new target implies 27% upside potential. The firm said the higher price target reflects an improved adjusted EPS outlook tied to a recovery in Medicare Advantage, along with higher target multiples. Bernstein believes the company’s projected 16% adjusted EPS CAGR supports a higher valuation multiple during this cyclical recovery phase.

On May 26, Barclays raised its price target on UNH to $429 from $373 and kept an Overweight rating on the shares. The firm said it believes the stock movements across managed care companies following Q1 earnings reports are “durable.” Barclays added that it continues to favor managed care companies over healthcare facilities, noting that inflation and commercial mix are becoming larger sources of earnings risk for providers. The firm also adjusted ratings and price targets across the sector.

UnitedHealth Group Incorporated (NYSE:UNH) is a healthcare and well-being company. Its businesses include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare.

2. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 132

On May 26, BofA raised the firm’s price recommendation for Eli Lilly and Company (NYSE:LLY) to $1,251 from $1,133. It reiterated a Buy rating on the shares. The firm said it expects Lilly’s future revenue and profit growth to be driven by a doubling of GLP-1 U.S. market sales by 2033, the analyst told investors.

In separate news, Reuters reported on May 21 that Eli Lilly said its experimental obesity drug helped patients lose more than 28% of their weight over an 18-month period in a key clinical trial. The results could allow the company to seek regulatory approval and potentially launch the next-generation treatment next year.

The results were largely in line with Wall Street expectations and could position retatrutide as one of the most powerful weight-loss drugs in the growing obesity treatment market, where Lilly competes with Novo Nordisk.

Eli Lilly and Company (NYSE:LLY) is a medicine company that discovers, develops, manufactures, and markets pharmaceutical products through a single business segment focused on human pharmaceuticals.

1. Broadcom Inc. (NASDAQ:AVGO)

Number of Hedge Fund Holders: 173

On May 27, Broadcom Inc. (NASDAQ:AVGO) announced a partnership with Samsung Electronics to introduce a new broadband-focused reference platform for the global fixed wireless access (FWA) market. The platform combines Broadcom’s BCM6776 Wi-Fi 8 System-on-Chip (SoC) with Samsung’s B1320 5G Modem.

The companies said the platform is the first to bring together 3GPP Release 17 connectivity and the emerging Wi-Fi 8 (IEEE 802.11bn) standard. With broadband demand continuing to grow worldwide, the new platform is designed to improve reliability and deliver more stable network performance.

Broadcom and Samsung said the platform was built with large-scale deployment in mind. It offers mobile operators a cost-effective way to provide fiber-like broadband services while supporting faster service development and wider ecosystem expansion. Several major original equipment manufacturers (OEMs) are already integrating the B1320 and BCM6776 platform into their next-generation gateway products, according to the companies.

Broadcom Inc. (NASDAQ:AVGO) develops semiconductors and infrastructure software for organizations handling complex and mission-critical technology operations.

While we acknowledge the potential of AVGO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AVGO and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best Blue Chip Stocks to Buy for Your Retirement Portfolio and 10 Best June Dividend Stocks to Buy

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.